EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis

Ryan A Adams, Ying-Ting Wang, Alison G Barber, Kristina Hamel, Andrew Imfeld, Luke Burman, Kaitlyn Rauch, Yeeting E Chong, Angelica Villanueva, Lauren Guy, Wayne Liu, Crystal Manzo und 16 weitere

Journal of Biological Chemistry · 2026-11 · 302 (11) · 113586

DOI: 10.1016/j.jbc.2026.113586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-11. Verfasst von Ryan A Adams und 27 weiteren Autor:innen. Beteiligte Einrichtung: aTyr Pharma, San Diego, California, USA. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Technology Commission - Hong Kong, aTyr, Innovation and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis remains a major global health challenge with limited therapies that only slow disease progression. While the aminoacyl-tRNA synthetase (aaRS) family is known to utilize evolutionarily appended domains as extracellular signaling molecules, their role in regulating the homeostasis of the fibrotic process is poorly defined. We identify a natural proteolytic fragment of aspartyl-tRNA synthetase (DARS), termed DARS-N1, that selectively triggers apoptosis in myofibroblasts by targeting latent-transforming growth factor beta binding protein 1 (LTBP-1) on the extracellular matrix (ECM). This active N-terminal fragment of DARS reduces focal adhesion kinase (FAK) activation in undifferentiated fibroblasts and myofibroblasts, while only myofibroblasts exhibit inadequate cell-matrix attachment leading to loss of anchorage-dependent survival and promotion of apoptosis. We utilized ATYR0101, a therapeutic form of DARS-N1 engineered for extended serum exposure, to demonstrate anti-fibrotic activity in lung (bleomycin). Spatial transcriptomics analysis showed that ATYR0101 activates a restorative program promoting the return to a healthy state. These findings highlight ATYR0101's potential as a transformative therapy for disrupting the process of chronic tissue fibrosis.

Schlagwörter

Stichwörter der Autor:innen

FAKaminoacyl tRNA synthetaseanoikisapoptosisfibrosismitochondriamyofibroblasts

Autor:innen und Institutionen

  • aTyr Pharma, San Diego, California, USA.
  • IAS HKUST R&D Laboratory, Institute for Advanced Study, Hong Kong University of Science and Technology, Kowloon, Hong Kong, China; Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong,…
  • Biological Cryo-EM Center, The Hong Kong University of Science and Technology, Hong Kong, China.
  • Alimentiv Inc, London, Ontario, Canada.
  • Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China.
  • aTyr Pharma, San Diego, California, USA. Electronic address: lnangle@atyrpharma.com.

Förderung

  • Innovation and Technology Commission - Hong Kong
  • aTyr
  • Innovation and Technology Commission

Zitieren

APA

Adams, R. A., Wang, Y. T., Barber, A. G., Hamel, K., Imfeld, A., Burman, L., Rauch, K., Chong, Y. E., Villanueva, A., Guy, L., Liu, W., Manzo, C., Klopp-Savino, S., Polizzi, C., Stamps, J., Pastenes, M., Tian, H., Fung, C. P., Zhang, Y., …, & Nangle, L. A. (2026). Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis. Journal of Biological Chemistry, 302(11), 113586. https://doi.org/10.1016/j.jbc.2026.113586

Vancouver

Adams RA, Wang YT, Barber AG, Hamel K, Imfeld A, Burman L, et al. Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis. Journal of Biological Chemistry. 2026;302(11):113586. doi:10.1016/j.jbc.2026.113586

BibTeX
@article{Adams2026,
  author = {Adams, Ryan A and Wang, Ying-Ting and Barber, Alison G and Hamel, Kristina and Imfeld, Andrew and Burman, Luke and Rauch, Kaitlyn and Chong, Yeeting E and Villanueva, Angelica and Guy, Lauren and Liu, Wayne and Manzo, Crystal and Klopp-Savino, Sofia and Polizzi, Clara and Stamps, Jasmine and Pastenes, Max and Tian, Honglei and Fung, Chun Po and Zhang, Yingyi and Ho, Kwok Wa Hugo and Sangiorgi, Bruno and Dillingham, Blythe and Brust, Tarsis F and Chiang, Kyle P and Wu, Zhenguo and Xu, Zhiwen and Burkart, Christoph and Nangle, Leslie A},
  title = {Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  volume = {302},
  number = {11},
  pages = {113586},
  doi = {10.1016/j.jbc.2026.113586}
}
Kostenlos starten →